| GC17389-100mg |
|
121577-32-0 |
Gatifloxacin hydrochloride
|
0 |
C19H23ClFN3O4 |
|
|
|
| GC17389-5mg |
|
121577-32-0 |
Gatifloxacin hydrochloride
|
0 |
C19H23ClFN3O4 |
|
|
|
| GC17388-10mM (in 1mL DMSO) |
|
2060530-16-5 |
|
0 |
C17H22Cl2N2O3S |
|
|
|
| GC17388-25mg |
|
2060530-16-5 |
|
0 |
C17H22Cl2N2O3S |
|
|
|
| GC17388-10mg |
|
2060530-16-5 |
|
0 |
C17H22Cl2N2O3S |
|
|
|
| GC17386-10mM (in 1mL DMSO) |
|
1037184-44-3 |
|
0 |
C17H13Cl2NO4 |
|
|
|
| GC17386-100mg |
|
1037184-44-3 |
|
0 |
C17H13Cl2NO4 |
|
|
|
| GC17386-50mg |
|
1037184-44-3 |
|
0 |
C17H13Cl2NO4 |
|
|
|
| GC17386-10mg |
|
1037184-44-3 |
|
0 |
C17H13Cl2NO4 |
|
|
|
| GC17385-50mg |
|
1380424-42-9 |
|
0 |
C24H21F6NO7 |
|
|
|
| GC17385-10mg |
|
1380424-42-9 |
|
0 |
C24H21F6NO7 |
|
|
|
| GC17384-50mg |
|
136676-91-0 |
PD 123319 ditrifluoroacetate
|
0 |
C35H34F6N4O7 |
|
|
|
| GC17384-10mg |
|
136676-91-0 |
PD 123319 ditrifluoroacetate
|
0 |
C35H34F6N4O7 |
|
|
|
| GC17384-5mg |
|
136676-91-0 |
PD 123319 ditrifluoroacetate
|
0 |
C35H34F6N4O7 |
|
|
|
| GC17383-50mg |
|
179068-02-1 |
|
0 |
C17H14N2O3 |
|
|
|
| GC17383-10mg |
|
179068-02-1 |
|
0 |
C17H14N2O3 |
|
|
|
| GC17382-50mg |
|
185629-22-5 |
|
0 |
C23H26FNO4 |
|
|
|
| GC17382-10mg |
|
185629-22-5 |
|
0 |
C23H26FNO4 |
|
|
|
| GC17381-50mg |
|
24587-49-3 |
trans-4-Hydroxycrotonic acid
|
0 |
C4H6O3 |
|
|
|
| GC17381-10mg |
|
24587-49-3 |
trans-4-Hydroxycrotonic acid
|
0 |
C4H6O3 |
|
|
|
